AMZN
Amazon.com, Inc.
AMZN has the edge over SG overall, supported by lower modeled downside and stronger fundamentals.
SG
Sweetgreen, Inc.
SG's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
SG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Unavailable |
SG's revenue is currently stable, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over SG in the historical PE scenario, which offers more potential upside but is not a forecast.
SG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $9.04 | -27% |
| Fair | 73x | $10.88 | -12% |
| Current | 83x | $12.38 | — |
| Expensive | 86x | $12.94 | +4.5% |
Historical ranges are pointers, not guarantees.
SG's PE is 83x, but its earnings don't support one, so it isn't a reliable read right now.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
SG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect SG's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over SG on earnings, with more consistent year-over-year improvement.
SG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.15 | +$1.12 |
| Q2 2026 | $0.10 | +$0.94 |
| Q1 2026 | $0.12 | +$0.89 |
| Q4 2025 | -$1.14 | -$0.35 |
| Q3 2025 | -$0.97 | -$0.18 |
| Q2 2025 | -$0.84 | -$0.01 |
| Q1 2025 | -$0.77 | +$0.17 |
| Q4 2024 | -$0.79 | +$0.22 |
SG has returned to profit: it earned $0.15 per share over the past year, after losing money the year before. Its recent earnings include one-off gains.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over SG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over SG on profitability, with a higher operating margin.
SG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $176M | +2.1% |
| Q2 2026 | $192.7M | +3.8% |
| Q1 2026 | $161.5M | -2.9% |
| Q4 2025 | $155.2M | -3.5% |
| Q3 2025 | $172.4M | -0.6% |
| Q2 2025 | $185.6M | +0.5% |
| Q1 2025 | $166.3M | +5.4% |
| Q4 2024 | $160.9M | +5.1% |
SG's revenue grew through 2024 and has held roughly level since: $176M last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -18% | +3 points |
| Q2 2026 | -14% | 0 points |
| Q1 2026 | -21% | -4.1 points |
| Q4 2025 | -31% | -11 points |
| Q3 2025 | -21% | -8.8 points |
| Q2 2025 | -14% | -5.5 points |
| Q1 2025 | -17% | -0.1 points |
| Q4 2024 | -20% | -0.4 points |
SG's operating margin was −18% last quarter, up 3 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
SG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$22.1M | +$15.1M |
| Q2 2026 | -$10.6M | +$2.6M |
| Q1 2026 | -$29.6M | +$302K |
| Q4 2025 | -$39M | -$18.4M |
| Q3 2025 | -$37.2M | -$26.9M |
| Q2 2025 | -$13.1M | -$13M |
| Q1 2025 | -$29.9M | -$19.9M |
| Q4 2024 | -$20.6M | -$14.7M |
SG has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
SG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +212K shares |
| 1 year | +0.7% | +828K shares |
| 3 years | +6.2% | +6.9M shares |
| 5 years | +10% | +10.9M shares |
| Available history | +10% | +10.9M shares |
SG has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
SG Net Leverage
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
SG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 72.3 | Overbought |
| Stochastic | 88.8 | Overbought |
SG's weekly RSI is 72 (overbought) and its Stochastic is 89 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over SG on valuation relative to its sector.
SG PE vs Consumer Cyclical Sector
| Metric | SG | Sector median | Relative |
|---|---|---|---|
| PE | 83x | 18x | 358% above |
| PE % | 78 | 56 | 22 pts above |
SG is trading at 83x earnings, a 358% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over SG on trend strength, trading above more of its moving averages.
SG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.3 | 20% above |
| 20 week MA | $8.29 | 49% above |
| 50 week MA | $7.50 | 65% above |
| 100 week MA | $12.2 | 1.7% above |
| 200 week MA | $15.7 | 21% below |
SG has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 21% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
SG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $53.0 | $31.4 | -41% |
| 2022 | $31.4 | $8.83 | -72% |
| 2023 | $8.83 | $11.3 | +28% |
| 2024 | $11.3 | $32.4 | +186% |
| 2025 | $32.4 | $6.97 | -78% |
| 2026 YTD | $6.97 | $12.4 | +78% |
SG has the edge over AMZN on returns for 2026, with the stronger performance.